在拉斯穆森脑炎中mTOR信号通路的异常激活
Jiao Qiao1,2, Chongyang Tang1,3, Mingguo Xie1
1Department of Neurosurgery, Center of Epilepsy, Beijing Institute for Brain Disorders, Sanbo Brain Hospital, Capital Medical University, 50 Xiang Shan Yi-Ke-Song, Haidian District, Beijing, 100093, China.
Scientific reports
|February 21, 2025
概括
在拉斯穆森脑炎 (RE) 脑组织中观察到包括mTORC1和mTORC2在内的拉巴胺素 (mTOR) 途径机械标的异常激活,这表明RE治疗的新疗法标.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 病理学 病理学 病理学
背景情况:
- 拉斯穆森脑炎 (RE) 是一种罕见的神经疾病,其特征是渐进的炎症和神经元损失.
- 了解 RE 病原发生的分子机制对于开发有效的治疗方法至关重要.
研究的目的:
- 研究RE患者大脑组织中拉巴胺素 (mTOR) 途径激活的机械性标.
- 为了将RE中的mTOR路径标记与对照样本和焦点皮质发育不良 (FCD) 样本进行比较.
- 确定可再生能源的潜在治疗点.
主要方法:
- 西方涂抹测量mTOR通路信号标记物 (-S6,-AKT,-MAPK,-Stat3) 的数量.
- 免疫组织化学 (IHC) 和免疫光学 (IF) 用于评估细胞特异性生物标志物表达和组织异常.
- 从RE患者,对照组和FCD患者 (阳性对照组) 的手术脑组织样本的分析.
主要成果:
- 与对照组相比,RE样本中发现了-S6,-AKT,-MAPK和-Stat3的显著增加水平,表明mTORC1和mTORC2的激活.
- p-S6和p-AKT在异位外和巨型神经元,微质细胞和星球细胞中表达.
- p-MAPK表达与RE进展相关,主要在星球细胞和血管中.
- -ULK1在亡神经元中;贝克林-1在微质结节和异常神经元中.
结论:
- 在拉斯穆森脑炎中证明了mtORC1和mtORC2的异常激活.
- 这些发现为RE病原发生提供了新的见解.
- 该研究强调了RE药物干预的潜在新疗法目标.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
MAPK Signaling Cascades
5.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.1K
The Ras Gene
6.1K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.1K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K


